1. A novel and inexpensive application of RNAi technology to protect shrimp from viral disease.
- Author
-
Saksmerprome V, Charoonnart P, Gangnonngiw W, and Withyachumnarnkul B
- Subjects
- Animals, Escherichia coli genetics, Escherichia coli metabolism, Immunohistochemistry, Penaeidae enzymology, Penaeidae genetics, RNA, Double-Stranded administration & dosage, RNA, Double-Stranded genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Roniviridae enzymology, Roniviridae genetics, Viral Proteins genetics, Viral Proteins metabolism, Virus Replication, Biotechnology economics, Biotechnology methods, Penaeidae immunology, Penaeidae virology, RNA Interference immunology, RNA, Double-Stranded metabolism, RNA-Dependent RNA Polymerase administration & dosage, RNA-Dependent RNA Polymerase genetics, RNA-Dependent RNA Polymerase metabolism, Roniviridae pathogenicity
- Abstract
Large-scale production of long dsRNA is needed if antiviral applications of RNAi are to succeed in shrimp farm operations. A novel hairpin-RNA expression vector was developed based on the RNA-dependent RNA polymerase (RdRp) gene of yellow head virus (YHV), the cause of a lethal shrimp disease. Using transformed RNase-deficient Escherichia coli, large amounts (approximately 5 mg dsRNA from 130 ml bacterial culture) of long dsRNA (>300 nt) were produced. Large-scale in vivo dsRNA production was approximately one-fourth the cost of production of a commercial in vitro transcription kit. The hairpin-RNA consisted of the target RdRp sequence ("forward") and a 100-base shortened version of its inverted repeat ("reverse") to introduce a loop and bypass the difficulty of including a small "loop" connector into the "carrier" vector. A test group of whiteleg shrimp Penaeus (Litopenaeus) vannamei (approximately 10-15 g) was injected with 25 microg of this dsRNA 1-day prior to YHV challenge while control groups were injected with NaCl solution or similarly prepared dsGFP-RNA. The group injected with YHV-specific dsRNA did not develop yellow head disease during 14-day of observation after YHV challenge, whereas the control groups injected with NaCl and dsGFP-RNA developed gross signs of yellow head disease and died within 7-10 days after challenge. Quantitative RT-PCR and immunohistochemistry revealed that both viral mRNA and viral proteins were suppressed in the protected shrimp.
- Published
- 2009
- Full Text
- View/download PDF